- +86 0371-86658258
- info@coreychem.com
English
Purity: 98%;
Appearance: Off-white powder
| Product Name | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide |
| Synonyms | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide;1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide;phenyl(4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-;4-hydroxy-7-methoxyquinoline-6-carboxamide;lenvaim-C;LenvatinibImpurity19;6-Quinolinecarboxamide,1,4-dihydro-7-methoxy-4-oxo-;7-methoxy-4-oxo-1,4-dihydro-6-quinolinecarboxamide |
| CAS NO | 417724-81-3 |
| Purity | 95% |
| MF | C11H10N2O3 |
| MW | 218.21 |
| Contact | selina@coreychem.com |
1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide (CAS: 417724-81-3) serves as a crucial metabolite and synthetic intermediate for the anticancer drug Lenvatinib. Lenvatinib is an orally active inhibitor of multiple receptor tyrosine kinases—such as VEGF, FGF, and SCF receptors—and is widely used to block angiogenesis and tumor growth. As such, this quinoline derivative plays a key role in both metabolic studies and pharmaceutical synthesis related to Lenvatinib
1KG per bag; Or package according to customer needs
